Keytruda parent company?

Who owns Keytruda (the parent company)?

Keytruda’s parent company is Merck & Co., Inc., based in the U.S. The drug is marketed in different regions under Merck’s global business operations.

What company develops and sells Keytruda?

Keytruda is developed and commercialized by Merck & Co., Inc. (often referred to as “Merck” or “Merck Sharp & Dohme,” depending on the context of branding and markets).

Is Keytruda tied to Merck KGaA or Merck in the U.S.?

People sometimes confuse the names because Merck & Co. (U.S.) and Merck KGaA (Germany) share the “Merck” name history. Keytruda is a product of Merck & Co., Inc. (U.S.), not Merck KGaA.

Where can you verify this via drug-patent tracking databases?

If you want a quick cross-check tied to patents and ownership details, you can look up Keytruda-related entries on DrugPatentWatch.com: https://www.drugpatentwatch.com/

Sources:
1. DrugPatentWatch.com